CORTISONE AND ITS ANALOGUES
|
|
- Cathleen McDaniel
- 5 years ago
- Views:
Transcription
1 CORTISONE AND ITS ANALOGUES IN DERMATOLOGY By G. C. WELLS, M.B., M.R.C.P. Senior Lecturer in Dermatology, St. John's Hospital for Diseases of the Skin, London Dermatology is one of the branches of medicine in which the usefulness of cortisone and its analogues is most appreciated. These steroids are vitally important in the most serious skin diseases, such as pemphigus vulgaris and acute lupus erythematosus, and they are helpful in many others, such as exfoliative dermatitis and lichen planus. With systemic therapy it should be realized that large doses of steroids are needed in order to suppress inflammation in the skin and it is seldom worth while using less than ioo mg. of cortisone daily, and often very much more is required. The other great difficulty is the rebound which is likely to occur in many skin diseases some days after stopping steroid therapy, and sometimes the relapse results in a worse state of the disease than existed before treatment. In some cases large doses of cortisone have to be continued over many months with all the attendant dangers of serious complications such as intercurrent infection, peptic ulceration, psychotic illness, thrombosis, glycosuria, disturbance of fluid and electrolyte balance and osteoporosis. On the other hand, hydrocortisone locally applied to the skin is free from the dangers of systemic effects if used in reasonable amounts, and it is used to suppress inflammation and itching in some common skin conditions which will be briefly discussed. The objections to this use of hydrocortisone are its high cost and the occasional aggravation of surface infection if it is wrongly used, as in impetigo; or that an important diagnosis should be overlooked while symptoms are being suppressed with topical hydrocortisone. A brief account will be given of some important applications of systemic steroid therapy in dermatology, but the so-called connective tissue diseases (systemic lupus erythematosus, dermatomyositis, scleroderma and polyarteritis nodosa) will not be discussed. This will be followed by some notes on local application of hydrocortisone as an ointment or cream and by intradermal injection. Finally, the effects of these steroids on skin reactions will be discussed. 335 Pemphigus Vulgaris It is in true pemphigus that we have the greatest need for long-term steroid therapy. In this disease of unknown cause, blisters appear widely over the skin surface and in the mouth, leading to large erosions. The blister forms within the epithelium, apparently by loss of cohesion between epithelial cells, and it is by study of the cytology and histology of the blisters that pemphigus may be separated from all the other bullous eruptions. Before cortisone became available, patients with pemphigus would usually die within about two years, and those last months of their lives were fraught with pain and misery. With steroid therapy, blistering can be suppressed and life prolonged and, indeed, there are sometimes remissions in which the treatment can be suspended for a year or more. Very large doses of steroids are often needed to bring the blistering under control, whereupon the dose is gradually reduced to that which will maintain a patient almost free of blistering. During the first two or three weeks of treatment, dosage of the order of 400 or 500 mg. cortisone daily must usually be given, and sometimes i or 2 g. daily are necessary to bring the disease under control. For maintenance, it may be necessary to continue with 150 or 200 mg. daily for many months, though gradual further reduction must be attempted from time to time. Naturally these patients run the gauntlet of complications from cortisone, but at present there is no other satisfactory approach to control of the blistering. I prefer to start treatment with cortisone and perhaps change to prednisone when the maintenance dose has been established and when the patient is ready to leave hospital. In my experience, rapid build-up of prednisone to very large dosage at the start of treatment has led to peptic ulceration and even to perforation; of course this can happen with comparable dosage of cortisone, but possibly it is less likely. Measures to combat salt and water retention with these large doses of cortisone must be taken promptly and it is
2 336 FIG. i.-pemphigoid of seven months' duration in a woman of 58. advisable to check the patient's weight daily. When diuretics are used to reduce oedema, close check must be kept on the electrolyte balance Pemphigoid The commonest of these major bullous diseases lacks a satisfactory label, and under the term ' pemphigoid' there may lurk more than one clinical entity; but at least we must keep true pemphigus and dermatitis herpetiformis separate from it. Pemphigoid is usually met with in old people, and while the ultimate prognosis is good, extensive blistering may endanger life in the aged or debilitated. The blisters are densely packed on -the limbs (Fig. i) and are often set in plaques of erythema which may extend onto the abdomen and chest, but the mucous membranes are seldom affected. Another distinction: from pemphigus is the histopathology of the blister which in pemphigoid is subepidermal. Pemphigoid, unlike dermatitis herpetiformis, does not respond to empirical treatment with sulphapiridine or with diamino diphenyl sulphone, nor is it as chronic, nor as itchy. Pemphigoid responds satisfactorily to treatment with cortisone or to parenteral ACTH, and the POSTGRADUATE MEDICAL JOURNAL,.7Utie I 9.58 FIG. 2.-The same after three weeks of treatment with prednisone (40 mg. daily). dosage does not need to be as high as in pemphigus. While some patients relapse when the steroid therapy is stopped, there is, after some months, a fair chance of complete recovery, so that attempts should be made from time to time to withdraw cortisone. Fig. 2 shows the effect of giving prednisone mg., 40 daily, for three weeks. Bullous Erythema Multiforme Typical erythema multiforme is transient and not very distressing, and it is, therefore, not in need of steroid therapy. Severe erythema multiforme with predilection for mucous membranes (Stevens Johnson Syndrome) demands symptomatic relief, and cortisone is effective. After a few weeks the cortisone may be withdrawn without likelihood of relapse. Antibiotic cover for secondary infection may be needed. Drug Eruptions Many drug eruptions will subside quickly enough when the offending drug has been stopped. Occasionally the reaction is so severe as to endanger life or to cause great discomfort. For instance, sulphonamide sensitivity may have been induced
3 Eczema In the general run of eczemas, whether constitutuy.ne 1958 WELLS: Cortisone and its Analogues in Dermatology 37 by previous skiin applications, whereafter even a small amount by mouth may provoke a widespread and distressing eruption which would take six or seven weeks to disappear. We have recently treated two such cases with slow intravenous infusions of 20 mg. ACTH daily with rapid relief, and undoubtedly the period of illness was curtailed. In both cases it was possible to stop treatment after two weeks, without relapse. Two kinds of drug reaction are liable to be severe and very prolonged. These are generalized exfoliative erythrodermia and lichenoid eruptions, and they may be produced by gold salts, arsenicals, mercurials and by mepacrine. A useful degree of suppression can be effected by steroids, though for many months there is a tendency for relapse on withdrawal. Doses of the order of I00 to 200 mg. cortisone daily are likely to be needed. Therapeutic Reactions Rapid destruction of infecting organisms at the start of chemotherapy may result in toxic or allergic reactions on the part of the host. The Herxheimer reaction, which occurs when syphilis is treated, is an example of this kind. The reaction may be blanketed by giving cortisone concurrently with penicillin during the first few days of antisyphilitic treatment. Again, during the treatment of lepromatous leprosy with sulphones, rather violent lepra reactions may occur with fever and erythema nodosum. It is sometimes justifiable to give cortisone to suppress this kind of reaction, in order to press on with effective doses of diaminodiphenyl sulphone. Generalized Exfoliative Erythrodermia Exfoliative dermatitis, once it has become universal, is liable to persist for many months or even years and carries with it, besides discomfort and disability, considerable danger from surface infection and protein depletion. Consideration of aetiology is important. Those cases that can be related to a specific drug eruption are usually much helped by steroids, and eventually there will be full recovery. The commonest type of case, however, is that which has started with eczema, and the eczema has generalized. These cases usually need steroid treatment under which control is adequate, but treatment usually needs to be carried over many months, and relapse on withdrawal of cortisone is the rule. Psoriasis sometimes generalizes in this way. While universal psoriasis undoubtedly responds to large doses of steroids, there is a tendency for the erythrodermia to break through even though cortisone is continued, and for suppression cortisone dosage has to be very large, for example, 200 mg. daily. On withdrawal of cortisone the psoriasis relapses fully, and usually one is left with the feeling that nothing has been gained or harm has been done. In my opinion the temptation to use steroids for psoriasis should be altogether resisted. The rare type of generalized erythrodermia that sometimes accompanies a reticulosis or lymphoma may be bedevilled by severe itching, in which case it may be justifiable to use sufficient cortisone to suppress symptoms, while realizing that there will be no curative effect on the underlying disease. Lichen Planus Lichen planus usually resolves spontaneously within a year, and while the itching may be troublesome, the disease is usually not serious enough to justify systemic steroid therapy. Sometimes the disease drags on so long, and itching is so distressing that treatment with slow intravenous infusion of ACTH or with cortisone is given. The results are excellent. Relief from itching occurs within 48 hr. and resolution of the lichen papules is well under way within three weeks. Often, after treatment has stopped, relapse is only moderate or slight and there is no particular tendency to bad rebound as in eczema. Lichen planus may severely damage the scalp and, in cases where active damage is apparent, it may be reasonable to give steroids to prevent further extension of permanent bald patches. Of all the cutaneous diseases, lichen planus is the one upon which cortisone has the most distinct effect in the removal of pathological infiltrate, besides suppressing symptoms. Atopic Eczema While the clinical manifestations of the eczemaasthma syndrome can be effectively suppressed by cortisone or ACTH, it is seldom justifiable to use this kind of treatment for what is a labile constitutional disease. All too often a casual term of treatment is undertaken to get the patient over a difficult episode, but withdrawal often results in severe relapse so that it becomes difficult to stop he cortisone. Occasionally the eczema is so severe that life is almost insupportable outside of hospital, and then one has to decide whether to embark upon a course of steroid therapy with no likelihood of being able to discontinue it. In most of these patients it requires at least I00 mg. of cortisone daily to suppress the eczema or prurigo, though there are fluctuations in the requirement. Children require almost the full adult dose, and only the most severe and intractable childhood eczema or Besnier's prurigo should be treated with cortisone.
4 '.38X tional, inummular, seborrhoeic, conitact or \ aricose, steroid therapy should not be undertaken without very careful consideration. Only if the eczema is very widespread and unresponsive to conventional therapy and to hospitalization should steroids be used. All too often on stopping the treatment the relapse is severe, and the ultimate state of the patient may be worse than the first. Valuable information has been gained by the study of the effects of short courses of steroid therapy on severe eczema, and this experience has been recorded by Dowling (I953) and is included in the first report of the Medical Research Council Panel on the dermatological applications of ACTH and cortisone (I954). Alopecia Areata In cases of extensive or long-standing alopecia areata, Dillaha and Rothman (1952) showed that large doses of cortisone would produce growth of hair. As soon as the cortisone was stopped the hair fell out again and there was no long-term advantage. This effect of cortisone remains as a point of interest in a totally obscure disease, but it is of no practical therapeutic value. TOPICAL APPLICATION OF HYDROCORTISONE Hydrocortisone acetate or free alcohol in strength of l to i per cent. is effective in an ointment base, cream or lotion. A small amount gently rubbed into the skin for about a minute twice daily is usually sufficient. Suppression of the exudative phase of inflammation is seen, as for example, in eczema, and itching is reduced. Treatment with topical hydrocortisone is only suitable for eczema of quite limited extent, as the cost of treating large areas is prohibitive. Hydrocortisone is particularly valuable in relieving anogenital pruritus. Response is good in seborrhoeic eczema, atopic eczema, contact eczema and discoid eczema. In lichenification there may be some relief of itching, but resolution is unusual. On the other hand, psoriasis is quite unresponsive to these applications (except for genital lesions) and chronic discoid lupus erythematosus, lichen planus and many other dermatoses are unaffected by local hydrocortisone. The ease of application and cleanliness of these preparations has added greatly to their popularity, particularly for those parts of the body where they are most effective (the face and the flexures and genital region). Sometimes through faulty diagnosis an infective condition such as impetigo has been treated with hydrocortisone and it may be aggravated thereby, but, on the whole, exacerbation of local infection has been less than one might have expected. It is clear that most of these conditions are relieved by hydro- 3POST(;RADIUATE NIEDI CAI. JOURNAL. YUM't 1 958X cortisone rather thani cured, and it is usually necessary to proceed to more active treatment once the inflammation has been brought under control. A summary of the experience of the staff of St. John's Hospital for Diseases of the Skin with topical hydrocortisone has recently been published (1I957)- Injection of Hydrocortisone Intradermal injection of hydrocortisone has so far proved to be of little importance in dermatology, though there are a few interesting applications. In alopecia areata for instance, regrowth of a tuft of hair at the site of injection of hydrocortisone is academically interesting rather than cosmetically satisfactory. Small plaques or nodules of lichen simplex or lichen planus may respond to injection and individual nodules of sarcoid may be influenced in this way. The results from injecting hydrocortisone into keloids have not been very encouraging, but undoubtedly some keloids have been reduced by this method and it is a form of treatment which does not seem to do harm. The usual technique has been to inject io mg. of hydrocortisone, suspended in the usual diluting fluid, together with hyaluronidase and novocaine. It is difficult to get a good dispersion of hydrocortisone crystals, and it is not unusual for the steroid to remain visible in the skin for a few months. The crystals may provoke a foreign body kind of cutaneous reaction, together with a depressed ' scar' which is, however, not permanent. This reaction (investigated in detail by Goldman et al., 1953) has discouraged the use of hydrocortisone injections about the face. The Effect of Steroids on Skin Reactions Objective tests for the local action of hydrocortisone in the skin are less easy to arrange than might be imagined, and most of our information comes from treating areas of eczema. Effective penetration of the hydrocortisone preparations into the skin is important and may be the main factor in regional differences of response. For example, eczema of the face is more responsive than eczema on the extremity, and presumably the hydrocortisone penetrates better into areas with thin epithelium and numerous pilosebaceous units. It is worth considering the known reactions of the skin and the effects of steroids upon them. Immediate Wealing Response The urticarial weal may be produced by pharmacological agents such as histamine, or indirectly by allergic reactions to foreign proteins, introduced into the dermis by prick, scratch or injection. The effect of local hydrocortisone or of systemic cortisone or ACTH on the immediate urticarial skin
5 i7u ie 1958 WELLS: Cortisone and its Anialogues in Dermatology response is minimal. This may be correlated with the fact that the steroids exert little or no beneficial effect in clinical urticaria. Sunburn If hydrocortisone is applied to the skin immediately after exposure to ultra-violet light or sunlight, the subsequent erythema is no different from controls. Both the urticarial response and erythema of ultra-violet light are not obviously reduced if the test subject has been given prior cortisone or ACTH, but with careful measurements Holti (I956) has shown slight reduction of these reactions experimentally. The effect of prior cortisone and locally applied hydrocortisone in reducing subsequent X-ray erythema is worthy of further study (Scott and Kalz, 1956). Delayed Allergic Responses in the Skin The Mantoux reaction may be altered when the patient is receiving cortisone, or if cortisone acetate is injected with the tuberculin. While the reactions in tuberculin-sensitive patients are reduced, Citron and Scadding (I957) have shown increased reactions in some patients wvith sarcoidosis. Apparently suppression by cortisone of the vascular component of tuberculin allergy may enhance the reaction by allowing the tuberculin to remain at the site of injection. Eczematous reactions to allergens applied as patch tests do not lend themselves well to combinatioin with local applications of hydrocortisone and usually no effect is demonstrable. Haxthausen (I956), choosing nickel-sensitive patients, improved the technique by introducing the allergen into the skin by iontophoresis. It was then possible to show suppression of the eczematous response in some cases when fluorohydrocortisone was applied. Again, some reduction of eczematous response to allergens applied as patch tests can be demonstrated when the patient is under the influence of systemic steroid therapy, but the results of such tests are often equivocal. Suirface Damage The effect of hydrocortisone oni experimental burns and on chemical damage has been difficult to assess, owing to difficulty in controlling the degree of damage, and because of variation of effect depending on the time of applications of the hydrocortisone relative to the damage. Controlled injury may be done to the skin surface by removing its keratin by repeatedly stripping an area with cellophane tape. After 20 or 30 strippings the area becomes red and shiny, and the erythema persists for several days and is confined to the denuded area. Hydrocortisone ointment applied to part of such a uniformly-stripped area causes reduction or suppression of the erythema. It takes about 4 hr. to effect this (Wells, I957) and the hydrocortisone exerts its effect for several hours, after which the erythema returns. Biopsies showed suppression of the perivascular lymphocytic infiltrate in the upper dermis in the hydrocortisone treated area, as compared with the control area. Thus, perhaps the most clearly demonstrable effect of locally-applied hydrocortisone in damaged skin is its suppression of vasodilatation in the subpapillary vascular plexus of the skin, together with reduction of small round cell perivascular infiltrate. This effect is reversible, if hydrocortisone applications are stopped. There appears to be slight delay in reconstitution of the skin surface under the influence of hydrocortisone. Healing Under the influence of systemic steroids, certain experimental animals and man show a delay in the vascular and fibroblastic components of cutaneous repair. Reference to this aspect of connective tissue repair will be found in Rothman (I954). Delay in wound-healing may add to the postoperative difficulties of cortisone-treated patients who have to undergo surgery. Summary i. An outline is given of the use of systemic steroids in the bullous diseases, drug eruptions, exfoliative erythrodermias, lichen planus and the eczemas. 2. The scope of topical therapy with hydrocortisone is reviewed, and mention is made of intradermal hydrocortisone injection. 3. The effect of cortisone and hydrocortisone on skin reactions is discussed. Acknowledgment I am indebted to the Institute of Dermatology for the photographs. (Photographer, R. J. Lunnon, Esq.) BIBLIOGRAPHY ('ITRON, K. NI., and SCADDING, J. G. (1957), Qtuart. 7. Med., 26, 277. D)ILLAHA, C. J., and RO'rHMAN, S. (X952), 7. Amer. 7ned. Ass., 150, 546. DOWLING, G. B. (1953), Trans. St. 7oh/n's Hosp. dermt. Soc. (Lonld.), 32, 06. First report of the M.R.C. panel on the dermatological applications of ACTH and cortisone (9j94), Brit. med. Y., ii, 1,307. GOLDMAN, L., O'HARA, H., and BASKETT, J. (1953),j. invest. Derm., 20, 271. HAXTHAUSEN, H. (1956), Ibid., 26, iii. HOLTI, G. (1956), Clin. Sci., I5, 41. NALZ, F., and SCOTT, A. (956), Y. invest. Derm., 26, I65. RO'FHMAN, S. ( 954), 'Physiology and Biochemistry of the University Skiu,' of Chicago Press. S'T'AFF of St. John's Hospital for Diseases of the Skin (1957), Practitioner, 178, 337. WELLS, G. C. (I957), Br-it. Y. Dernm., 69, Ii.
Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough
Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL
More informationPrescribing Information
Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division
More informationDermatology GP Referral Guidelines
Austin Health Dermatology Department holds 5 Clinic sessions to discuss and plan the treatment of with Dermatology conditions. Department of Health clinical urgency categories for specialist clinics Urgent:
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Psoriasis (excluding widespread plaque psoriasis) Psoriasis is a common chronic skin disorder. Estimates of the prevalence (proportion
More informationWhat's New in Oncodermatopathology: Immunotherapy Reactions
What's New in Oncodermatopathology: Immunotherapy Reactions Emily Y. Chu, M.D., Ph.D. Assistant Professor of Dermatology & Pathology and Laboratory Medicine Hospital of the University of Pennsylvania March
More informationPrescribing Information. Taro-Clobetasol. Taro-Clobetasol
Prescribing Information Pr Taro-Clobetasol Clobetasol Propionate Cream USP, 0.05% w/w Pr Taro-Clobetasol Clobetasol Propionate Ointment USP, 0.05% w/w Therapeutic Classification Topical corticosteroid
More informationContact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age
Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Dermatology Department The aim of this leaflet is to give you information about contact allergy
More informationPhototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])
Origination: 09/27/07 Revised: 08/2/17 Annual Review: 11/2/17 Purpose: To provide Phototherapy and Photochemotherapy Treatment (PUVA and UBV) guidelines for the Medical Department staff to reference when
More informationCOPYRIGHTED MATERIAL. Introduction CHAPTER 1. Introduction
CHAPTER 1 Introduction OVERVIEW The clinical features of skin lesions are related to the underlying pathological processes. Broadly skin conditions fall into three clinical groups: (a) those with a well-defined
More informationEczema & Dermatitis Clinical features: Histopathological features: Classification:
Eczema & Dermatitis Eczema is an inflammatory reactive pattern of skin to many and different stimuli characterized by itching, redness, scaling and clustered papulovesicles. Eczema and dermatitis are synonymous
More informationTable of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne
Table of Contents: Part 1 Medical Dermatology Chapter 1 Acneiform Disorders Acne Acne Vulgaris Pomade Acne Steroid Acne Infantile Acne Pediatric Perspectives Neonatal Acne (Acne Neonatorum) Pediatric Perspectives
More informationCommon Dermatological Conditions in Adults in Ghana. Margaret Lartey FWACP
Common Dermatological Conditions in Adults in Ghana Margaret Lartey FWACP Outline Introduction Two Common disorders Discussion Case 1 34 yr old female C/o pruritus of 2 months duration First episode Seen
More informationwith the clinical course. large by generally accepted standards were given, and these are mentioned. Some general features of routine treatment
POSTGRAD. MED. J. (1962), 38, 444 OF STEROID THERAPY IN DERMATOLOGY Experiences in 215 Cases C. M. RIDLEY, B.M., M.R.C.P. Senior Registrar, Skin Department, The London Hospital, London, E. i ALL treatment
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adhesive tape impression 1 Diff Quik in EPD diagnosis, 583 Allergy(ies). See also Food allergy; specific types, e.g., Culicoides hypersensitivity
More informationLUPUS. The Skin and Hair LUPUSUK 2015
5 LUPUS The Skin and Hair LUPUSUK 2015 LUPUS The Skin and Hair Skin problems are very common in lupus and many different types of issues can occur. This factsheet will discuss some of the more frequent
More informationGENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM
GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM Telogen effluvium is a form of diffuse hair loss that occurs during the telogen or resting phase of the hair growth cycle. Telogen
More informationDERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE
DERMATOLOGICAL EMERGENCIES DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE Dermatological Emergencies INFECTIONS ERYTHRODERMA DRUG ERUPTIONS STEVENS-JOHNSON
More informationWR SKIN. DERMATOLOGY
WR SKIN. DERMATOLOGY 1 Societies 11 History 13 Dictionaries. Encyclopaedias. Bibliographies Use for general works only. Classify with specific aspect 15 Classification. Nomenclature 16 Tables. Statistics
More informationRayos Prior Authorization Program Summary
Rayos Prior Authorization Program Summary FDA APPROVED INDICATIONS AND DOSAGE FDA-Approved Indications: 1 Agent Indication Dosage Rayos (prednisone delayedrelease tablet) as an anti-inflammatory or immunosuppressive
More informationfive series of cases were studied. Many of the patients treated by one
PHOTOSENSITIZATION IN THE TREATMENT OF PSORIASIS' ERVIN EPSTEIN, M.D. Oakland, Calif. Reviewing the symposium on the "Practical Management of Psoriasis" (1) one is impressed by the popularity gained by
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate
PACKAGE LEAFLET: INFORMATION FOR THE USER Flutarzole 0,05% w/w cream, Fluticasone propionate 1. IDENTIFICATION OF THE MEDICINAL PRODUCT 1.1. Trade name Flutarzole 1.2. Composition Active substance: Fluticasone
More informationCutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university
Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with
More informationDiphencyprone (DPC) treatment for Alopecia Areata
University Teaching Trust Diphencyprone (DPC) treatment for Alopecia Areata Irving Building Dermatology 0161 206 1846 All Rights Reserved 2017. Document for issue as handout. What is diphencyprone treatment?
More informationDESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S
Regardless of your future field of practice, you will be exposed to a considerable amount of dermatology and this rotation provides you the chance to see a range of skin diseases. You will have the opportunity
More informationTHE LATE THERAPEUTIC RESULTS PRODUCED BY LOW VOLTAGE ROENTGEN RAYS AND OTHER FORMS OF THERAPY IN CERTAIN BENIGN CHRONIC SKIN DISEASES*
THE LATE THERAPEUTIC RESULTS PRODUCED BY LOW VOLTAGE AND OTHER FORMS OF THERAPY IN CERTAIN BENIGN CHRONIC SKIN DISEASES* RUDOLF L. BAER, M.D., ALEXANDER BOROTA, M.D. AND MARION B. SULZBERGER, M.D. INTRODUCTION
More informationA CLINICAL EVALUATION OF THE EFFECTIVENESS OF HYDRYLLIN IN THE TREATMENT OF A VARIETY OF DERMATOSES*
A CLINICAL EVALUATION OF THE EFFECTIVENESS OF HYDRYLLIN IN THE TREATMENT OF A VARIETY OF DERMATOSES* WITH OBSERVATIONS ON THE EFFECT OF PLACEBO THERAPY DONALD M. PILLSBURY, M.D., DANIEL J. PERRY, M.D.
More informationConflicts of interest
Vulvar Cases 2 nd PANHELLANIC CONGRESS on Lower Genital Tract Disorders December 14-16 Grand Hyatt Athens Lynette J. Margesson MD FRCPC Assistant Professor of Obstetrics & Gynecology and Surgery(Dermatology)
More informationClinico Pathological Test SCPA605-Essential Pathology
Clinico Pathological Test SCPA605-Essential Pathology Somphong Narkpinit, M.D. Department of Pathogbiology, Faculty of Science, Mahidol University e-mail : somphong.nar@mahidol.ac.th Pathogenesis of allergic
More informationDiphencyprone (DCP) treatment
Page 1 of 5 Diphencyprone (DCP) treatment Introduction This leaflet gives you information about Diphencyprone (DCP) treatment for alopecia areata and answers some of the commonly asked questions. What
More informationCUTANEOUS SENSORY THRESHOLD STIMULATION WITH HIGH FREQUENCY SQUARE-WAVE CURRENT II. THE RELATIONSHIP OF BODY SITE AND OF SKIN DISEASES TO THE SENSORY
CUTANEOUS SENSORY THRESHOLD STIMULATION WITH HIGH FREQUENCY SQUARE-WAVE CURRENT II. THE RELATIONSHIP OF BODY SITE AND OF SKIN DISEASES TO THE SENSORY THRESHOLD* HARRY SIGEL, M.D. Potelunas, Meixner and
More informationICHTHYOSIS. What are the aims of this leaflet?
ICHTHYOSIS What are the aims of this leaflet? This leaflet has been written to help you understand more about ichthyosis. It will tell you what it is, the types of ichthyosis, what can be done about it,
More informationDr Emmy Babor GPSI Dermatology
Dr Emmy Babor GPSI Dermatology Wrinkles Sagging Thin skin (not all areas think about soles of feet) Loss of elasticity Pigmentary changes Dryness Loss of luminosity Baldness/ grey hair Increased nose
More informationIf a drug trigger is suspected, stop the offending drug as this may reduce the risk of relapse.
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationDiagnosis and Management of Common and Infective Skin Diseases in Children at primary care level
Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Dr Ng Su Yuen Paediatrician and Paediatric Dermatologist Hospital Pulau Pinang Outline Common inflammatory
More informationEmergency Dermatology Dr Melissa Barkham
Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010 Why is this important? Urgent recognition and treatment of dermatologic emergencies can be life saving and prevent long term
More informationEczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University
Eczema By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University Dermatitis= Eczema =Spongiosis Eczema Atopic Seborrheic Contact Allergic Irritant Nummular Asteatotic Stasis Neurodermatitis/Lichen Simplex
More informationCONDITIONS OF THE SKIN
CONDITIONS OF THE SKIN UCSF/SFGH Family & Community Medicine Residency Program Educational Objectives I. Knowledge The resident will be able to discuss the definition, diagnosis, and initial management
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationProlonged treatment of pulmonary sarcoidosis
Thorax (1967), 22, 519. Prolonged treatment of pulmonary sarcoidosis with corticosteroids CLIFFORD HOYLE, HUGH SMYLLIE1, AND DAVID LEAK From King's College Hospital, London The results are described of
More informationEmergency Dermatology. Emergency Dermatology
Emergency Dermatology These are rapidly progressive skin conditions and some are potentially lifethreatening. Early recognition is important to implement prompt supportive care and therapy. Some are drug
More informationA. Erythema multiforme and related diseases
Go Back to the Top To Order, Visit the Purchasing Page for Details Chapter Erythema, Erythroderma (Exfoliative Dermatitis) Erythema is caused by telangiectasia or hyperemia in the papillary and reticular
More informationEgyptian Dermatology Online Journal Vol. 6 No 1: 14, June 2010
Wells Syndrome H. Gammaz, H. Amer, A. Adly and S. Mahmoud Egyptian Dermatology Online Journal 6 (1): 14 Al-Haud Al-Marsoud Hospital, Cairo, Egypt e-mail: hananderma@hotmail.com Submitted: April 15, 2010
More informationTHE GAMMA GLOBULINS IN SOME DISEASES OF THE SKIN*
THE GAMMA GLOBULINS IN SOME DISEASES OF THE SKIN* THEODORE CORNBLEET, M.D. AND J. DE LA HUERGA, M.D. In 1939, Tiselius and Kabat' found that rabbits and monkeys immunized with pneumococcal antigens and
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abatacept for DLE, 493 for SLE, 497 Ablative therapies, localized, for cutaneous T-cell lymphoma, 502 506. See also Cutaneous T-cell lymphoma,
More informationUncommon clinical presentations of leprosy: apropos of three cases
Lepr Rev (2016) 87, 246 251 CASE REPORT Uncommon clinical presentations of leprosy: apropos of three cases RASHMI JINDAL* & NADIA SHIRAZI** *Department of Dermatology, Venereology & Leprosy, Himalayan
More informationTime to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service
Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...
More informationDepartment of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Bullous pemphigoid mimicking granulomatous inflammation Abhilasha Williams, Emy Abi Thomas. Department of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India. Egyptian Dermatology
More informationPRESCRIBING INFORMATION. Cream 0.025% Topical Corticosteroid
PRESCRIBING INFORMATION Pr PROPADERM (beclomethasone dipropionate) Cream 0.025% Topical Corticosteroid Valeant Canada LP 2150 St-Elzear Blvd. West, Laval, Quebec, Canada H7L 4A8 Date of preparation: October
More informationLichen Sclerosus. Exceptional healthcare, personally delivered
Lichen Sclerosus Exceptional healthcare, personally delivered Lichen Sclerosus (LS) is an itchy skin condition usually affecting genital skin, but it can occur elsewhere. It affects women more often than
More informationDrug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey
Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine
More informationCommonly Coded Conditions in Dermatology
Commonly Coded Conditions in Dermatology No part of this presentation may be reproduced or transmitted in any form or by any means (graphically, electronically, or mechanically, including photocopying,
More informationWhat Are the Different Forms?
SCARRING/CICATRICIAL ALOPECIA Scarring alopecia also known as cicatricial alopecia, refers to a collection of hair loss disorders that may be diagnosed in up to 3% of hair loss patients. It occurs worldwide
More information50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).
DUPISOR Composition Gel 50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). Action Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol
More informationGROUP 15 TOPICAL PREPARATIONS
- 105 - GROUP 15 15.1 DERMATOLOGICAL PREPARATIONS 15.1.1 TOPICAL ANTIFUNGALS CLOTRIMAZOLE Indication: Treatment of susceptible fungal infections, dermatophytoses, superficial mycoses, and cutaneous candidiasis
More information=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا
1 / 15 Erythema Annulare Centrifugum and Other Figurate Erythemas The figurate erythemas include a variety of eruptions characterized by annular and polycyclic lesions. Classification of this group has
More informationAn Approach to Common and not so Common Rashes in the Office FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
An Approach to Common and not so Common Rashes in the Office FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc 1 Common Rashes Tinea Corporis: Annular- this is not the only criteria Advancing erythematous
More informationClinical Studies of Blue Cap Spray in China (2002) Blue Cap Spray in the treatment of Psoriasis. Number of patients under treatment: 144.
April 2002 August 2002 Clinical Studies of Blue Cap Spray in China (2002) Blue Cap Spray in the treatment of Psoriasis. Number of patients under treatment: 144. Institution responsible for the tests Dermatology
More informationClinical profile of skin diseases in accident and emergency department attenders
Hong Kong J. Dermatol. Venereol. (2007) 15, 4-9 Original Article Clinical profile of skin diseases in accident and emergency department attenders CY Chan, KL Kam, CA Graham, TH Rainer, NM Luk Skin problems
More informationAllergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children
The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and
More informationCutaneous Adverse Drug Reactions in Domestic Animals. Katherine Doerr, DVM, Dip. ACVD. Veterinary Dermatology Center
Cutaneous Adverse Drug Reactions in Domestic Animals Katherine Doerr, DVM, Dip. ACVD Veterinary Dermatology Center Maitland, Rockledge, Waterford Lakes, FL Not highly studied in veterinary medicine Unknown
More informationDERMATOLOGY SKIN DISEASE: APPROACH TO DIAGNOSIS
DERMATOLOGY SKIN DISEASE: APPROACH TO DIAGNOSIS History Clinical Examination List and Prioritise Differentials Diagnostic Testing/Trials (eg Treatment Trial) Correlate All Findings History Signalment age,
More informationCHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia
CHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia BROCQ S ALOPECIA The term pseudopelade of Brocq is a source of much confusion and fruitless debate, and should be abandoned.
More informationBetnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate)
Package Leaflet: Information for the User Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate) Read all of this leaflet carefully before you start using this medicine because it contains
More informationChronic Hepatitis C. Risk Factors
Chronic Hepatitis C The hepatitis C virus is one of the most important causes of chronic liver disease in the United States. Almost 4 million Americans or 1.8 percent of the U.S. population have an antibody
More informationBlue light therapy. Blue light therapy has shown to have a positive effect on the following: Why to choose blue light?
PURE COMPLEXiON Blue light therapy Blue light therapy is an alternative form of therapy, where the narrow spectrum of the organic blue LED light is used to heal, treat and prevent skin diseases and other
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Excipient with known effect Cetyl alcohol For the full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Haelan Ointment Fludroxycortide 0.0125% w/w Ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Fludroxycortide 0.0125% w/w. Excipient
More informationEosinophilic Esophagitis (EoE)
Eosinophilic Esophagitis (EoE) 01.06.2016 EoE: immune-mediated disorder food or environmental antigens => Th2 inflammatory response. Key cytokines: IL-4, IL-5, and IL-13 stimulate the production of eotaxin-3
More informationPrednisolone-2 I -stearoylglycolate in scleritis
Brit. j. Ophthal. (1970) 54, 394 Prednisolone- -stearoylglycolate in scleritis S. S. HAYREH* AND P. G. WATSON Scleritis Clinic, Moorfields Eye Hospital, City Road, London, E.C. i Scleritis is one of the
More informationDisorders of the vulva
Vulval lesions Disorders of the vulva Terminology standardised by the International Society for the Study of Vulvovaginal Disease(ISSVD) Classification 1.Nonneoplastic epithelial disorders of vulva Lichen
More informationCHRONIC INFLAMMATION
CHRONIC INFLAMMATION Chronic inflammation is an inflammatory response of prolonged duration often for months, years or even indefinitely. Its prolonged course is proved by persistence of the causative
More informationSECOND SEASON PREDNISONE TREATMENT IN VERNAL CONJUNCTIVITIS WITH SPECIAL REFERENCE TO CORNEAL COMPLICATIONS*
Brit. J. Ophthal. (1958) 42, 674. SECOND SEASON PREDNISONE TREATMENT IN VERNAL CONJUNCTIVITIS WITH SPECIAL REFERENCE TO CORNEAL COMPLICATIONS* BY ELI NEUMANN From the Department of Ophthalmology, Hadassah
More informationLiv.52 in Dermatology
(Probe (1972): (XI), 2, 100) Liv.52 in Dermatology Behl, P.N., F.R.C.P., Director, Skin Institute, Delhi, India. INTRODUCTION Liver disorders are responsible for several skin disorders (Urbach, 1928; Belisario,
More informationLichen sclerosus. Lichen planus
Lichen sclerosus Lichen planus Dr Fiona Lewis, Consultant Dermatologist, Heatherwood and Wexham Park NHS Foundation Trust & St John s Institute of Dermatology, GSTT Outline Typical features of lichen sclerosus
More informationWhat is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics
What is? is a term derived from the Greek word psōra which means itch and is a common, long lasting, inflammatory skin condition which affects 1-3% of the UK population and about 80 million people worldwide.
More informationPOSTGRADUATE CERTIFICATE DERMATOLOGY. PgC & GPCert (DERM) SYLLABUS
POSTGRADUATE CERTIFICATE DERMATOLOGY PgC & GPCert (DERM) 2018 SYLLABUS POSTGRADUATE CERTIFICATE IN DERMATOLOGY PgC & GPCert (Derm) 2018 SYLLABUS This syllabus is designed as a guideline to the key areas
More informationPeople with eye allergies typically have symptoms that include: Eye Anatomy: What Do Eye Allergies Actually Effect?
Eye Allergies Eye Allergies People with eye allergies typically have symptoms that include: Itchy watery eyes Eyelid problems Dark circles around eyes Dry eyes Reactions to Contacts Let us help allow you
More informationCOURSE DESCRIPTION AND STUDY REGULATIONS
COURSE DESCRIPTION AND STUDY REGULATIONS Course: SKIN AND VENEREAL DISEASES Course type: COMPULSORY ELECTIVE ECTS credits: 6 Nominated teacher(s): prof. dr. Tomaž Lunder, izr. prof. dr. Mateja Dolenc-Voljč
More informationLidocaine PATIENT INFORMATION GUIDE
Lidocaine PATIENT INFORMATION GUIDE Table of Contents GLOSSARY............................................. 3 ABOUT RADIESSE (+)................................... 4 SAFETY INFORMATION.................................
More informationSandostene an(! Sandostene in Combination with Calcium: Clinical Effect in Various Dermatoses
Memoranda Sandostene an(! Sandostene in Combination with Calcium: Clinical Effect in Various Dermatoses By ALFRED L. W EINER and CLAUDIA RENE SIMON, Cincinnati, Ohio From the Departm ent of Dermatology
More informationCourse Regime. Course: SKIN AND VENEREAL DISEASES. Study Programme: Medicine. Year of the Course: 4 th study year.
Komisija za študijske zadeve UL Medicinske fakultete Vrazov trg 2 SI-1000 Ljubljana E: ksz@mf.uni-lj.si T: +386 1 543 7700 Course Regime Course: SKIN AND VENEREAL DISEASES Study Programme: Medicine Year
More information過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:
Allergy Centre 過敏病科中心 Eczema For enquiries and appointments, please contact us at: Allergy Centre 9/F, Li Shu Pui Block Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong Tel: 2835
More informationRash Decisions Approach to the patient with a skin condition
National Conference for Nurse Practitioners April 25, 2014 Rash Decisions Approach to the patient with a skin condition Margaret A. Bobonich, DNP, FNP C, DCNP, FAANP Assistant Professor, Case Western Reserve
More informationThursday, 21 October :53 - Last Updated Thursday, 11 November :27
1 / 15 2 / 15 3 / 15 4 / 15 Pityriasis Alba Background Pityriasis alba is a nonspecific dermatitis of unknown etiology that causes erythematous scaly patches. These resolve and leave areas of hypopigmentation
More information22 year old QH mare with regionally extensive alopecia and scaling on one front limb and ventral chest (Figure 1 and 2).
22 year old QH mare with regionally extensive alopecia and scaling on one front limb and ventral chest (Figure 1 and 2). Which of the following is the most likely disease? a. Sterile granuloma complex
More informationCitation The Journal of Dermatology, 37(8), available at
NAOSITE: Nagasaki University's Ac Title Two cases of blaschkitis with promi Author(s) Utani, Atsushi Citation The Journal of Dermatology, 37(8), Issue Date 2010-08 URL Right http://hdl.handle.net/10069/25634
More informationNarrow-band UVB PHOTOTHERAPY for Skin Diseases
Narrow-band UVB PHOTOTHERAPY for Skin Diseases By Dr. Manal Bosseila Cairo University, Egypt HISTORICAL ASPECT In 1978: Irradiation cabin with broad band UVB tubes was introduced for psoriasis & uremic
More informationCLINICAL EXPERIMENT ON LUPUS VULGARIS AND LUPUS MILIARIS
CLINICAL EXPERIMENT ON LUPUS VULGARIS AND LUPUS MILIARIS DISSEMINATUS FACIEI WITH SINGLE ADMINISTRATION OF CORTICOIDS* Antituberculous treatment combined with corticoids has been much studied in the field
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Hydrocortisone Ointment 1% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Ointment containing 1% micronised hydrocortisone Excipient(s)
More informationRECLASSIFICATION SUBMISSION. EUMOVATE Eczema and Dermatitis Cream. (Clobetasone butyrate 0.05%) From Prescription Only Medicine
RECLASSIFICATION SUBMISSION EUMOVATE Eczema and Dermatitis Cream (Clobetasone butyrate 0.05%) From Prescription Only Medicine To Pharmacist Only Medicine NOVEMBER 2000 MEETING PART A 1. International non-proprietary
More informationb) SKILLS The student should be able to
1. GOAL The aim of teaching the undergraduate student in Dermatology, S.T.D. and Leprology is to impart such knowledge and skills that may enable him to diagnose and treat common ailments and to refer
More informationInflammatory Dermatoses of the Vulva for the General/Gyn Pathologist with emphasis in the lichenoid pattern
Inflammatory Dermatoses of the Vulva for the General/Gyn Pathologist with emphasis in the lichenoid pattern By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor
More informationTOPCORT Cream/Ointment (Mometasone furoate 0.1%)
Published on: 10 Jul 2014 TOPCORT Cream/Ointment (Mometasone furoate 0.1%) Composition TOPCORT Cream Mometasone Furoate, IP... 0.1% w/w In a cream base... q.s. TOPCORT Ointment Mometasone Furoate, IP...
More informationZOFLUT Cream (Fluticasone propionate)
Published on: 23 Sep 2014 ZOFLUT Cream (Fluticasone propionate) Composition ZOFLUT Cream contains: Fluticasone Propionate,BP 0.05% w/w In a cream base.q.s. Dosage Form Topical cream Pharmacology Pharmacodynamics
More informationContents. QAaptm-2. CAaptei-3. CAaptm-4. Cftapte%-5. Qfiaptvt-6. QhapteK-7. Qkaptefc-8 Clinical Immunology and Allergy 71
Contents Ckaptm-1 Aaatomy, Physiology, Embryology, Bacteriology and Pathology ~ 1 Anatomy 1 Physiology 10 Embryology 14 Pathology 19 Bacteriology 22 Laboratory and other aids in dermatological pratice
More informationEXTERNAL ANOGENITAL WARTS
EXTERNAL ANOGENITAL WARTS Whats new HPV vaccination is now available to MSM under the age of 45 years attending Sexual Health Services. This vaccination is recommended even if a prior/current history of
More informationBC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab
BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab Protocol Code Tumour Group Contact Physicians LYCLLFLUDR Lymphoma Dr.
More informationEVALUATION OF TOPICAL DICHLOROXYQUINALDINE (STEROSAN) AS A THERAPEUTIC AGENT IN DERMATOLOGY* ARTHUR J. TRONSTEIN M.D.**
EVALUATION OF TOPICAL DICHLOROXYQUINALDINE (STEROSAN) AS A THERAPEUTIC AGENT IN DERMATOLOGY* ARTHUR J. TRONSTEIN M.D.** While certain of the oxyquinoline derivatives, such as Vioform and Quinolor Compound,
More informationSkin Disorders of the Nose in Dogs
Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Skin Disorders of the Nose in Dogs (Canine Nasal Dermatoses) Basics OVERVIEW Conditions
More informationDrug Allergy A Guide to Diagnosis and Management
Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:
More information